The serotonin transporter (SERT) is a member of the Na ؉ ͞Cl ؊ -dependent neurotransmitter transporter family and constitutes the target of several clinically important antidepressants. Here, replacement of serine-545 in the recombinant rat SERT by alanine was found to alter the cation dependence of serotonin uptake. Substrate transport was now driven as efficiently by LiCl as by NaCl without significant changes in serotonin affinity. Neurotransmitter transporters mediate the re-uptake of released neurotransmitters from the synaptic and nonsynaptic environment and play a key role in regulating synaptic transmission. Functional studies and sequence comparison of the transporters for different amino acid and monoamine transmitters have allowed their classification into two distinct families (1-3). The Na ϩ ͞Cl Ϫ -dependent transporter family includes the biogenic amine, glycine, and ␥-aminobutyric acid transporters, which share 12 putative transmembrane domains (TMDs) and a large extracellular loop between TMD3 and TMD4 that contains several potential N-glycosylation sites. The glutamate transporter family, in contrast, has a different transmembrane organization and needs K ϩ for substrate transport. All transmitter uptake systems display a stringent Na ϩ requirement for substrate translocation.
Neurotransmitter transporters mediate the re-uptake of released neurotransmitters from the synaptic and nonsynaptic environment and play a key role in regulating synaptic transmission. Functional studies and sequence comparison of the transporters for different amino acid and monoamine transmitters have allowed their classification into two distinct families (1) (2) (3) . The Na ϩ ͞Cl Ϫ -dependent transporter family includes the biogenic amine, glycine, and ␥-aminobutyric acid transporters, which share 12 putative transmembrane domains (TMDs) and a large extracellular loop between TMD3 and TMD4 that contains several potential N-glycosylation sites. The glutamate transporter family, in contrast, has a different transmembrane organization and needs K ϩ for substrate transport. All transmitter uptake systems display a stringent Na ϩ requirement for substrate translocation.
The serotonin transporter (SERT) has received particular attention because it represents the target of clinically important antidepressants as well as drugs of abuse and has been implicated in neurological and psychiatric disorders (4) . Pharmacological studies indicate the existence of distinct binding sites for tricyclic antidepressants and selective serotonin (5-hydroxytryptamine, 5-HT) re-uptake inhibitors on the SERT protein, and complex interactions between these sites as well as the substrate translocation site have been reported (5) (6) (7) (8) (9) (10) (11) . The cloning of SERT from different species (12) (13) (14) (15) (16) has fostered attempts to define structure-function relationships in this protein. Notably, analysis of chimeric human and rat SERT has revealed domains important for the selective binding of tricyclic antidepressants (10) . However, little is known about the amino acid side chains implicated in substrate and Na ϩ binding as well as 5-HT transport.
Serine residues are known to be crucial for the binding of catecholamines to adrenergic receptors (17) and for [ 3 H]dopamine uptake mediated by the dopamine transporter (18) . Here, we substituted alanine for three serine residues located in TMD11 of the rat SERT. The effects of these substitutions on 5-HT transport and antidepressant binding were then analyzed in transfected cells. Our results show that a serine residue at position 545 is important for the cation dependence of 5-HT transport. Additionally, this mutation affects the velocity of substrate translocation as well as binding of imipramine, but not citalopram. Site-Directed Mutagenesis. The XbaI͞HpaI fragment of a pCis construct containing the coding sequence of rat SERT (14) was subcloned into the eukaryotic expression vector pRC͞CMV (Invitrogen), to yield clone pRC-SERT. For the construction of mutants S545A, S555A, and S559A, singlestranded phagemid DNA derived from pRC-SERT was used as template, and point mutations were generated with synthetic oligonucleotides using an in vitro mutagenesis kit (Mutagene; Bio-Rad) as described (19, 20) . All mutations were verified by dideoxynucleotide sequencing.
MATERIALS AND METHODS

Chemicals
Cell Culture. Human embryonic kidney cells (HEK-293 cells; ATCC CRL 1573) were grown and transfected in 10-cm tissue culture dishes, or 24-well dishes, for membrane preparation and transport assay as described (11) .
Preparation of Membranes. Confluent HEK-293 cells were harvested and homogenized on ice in a Potter homogenizer. After nuclei and debris had been removed by centrifugation (11, 21) , membranes were collected by sedimentation at 20,000 ϫ g for 20 min at 4°C, resuspended in phosphatebuffered saline containing 5% (wt͞vol) glycerol, frozen in liquid nitrogen, and stored at Ϫ70°C.
[ 3 H]Antidepressant Binding and [ 3 H]5-HT Uptake. As reported previously (11, 21) , binding and transport experiments were performed with the indicated concentration of tritiated ligands using TB1 buffer (120 mM NaCl͞2 mM KCl͞1 mM CaCl 2 ͞1 mM MgCl 2 ͞10 mM Hepes, pH 7.5) or TB2, TB3, and TB4 buffers, in which NaCl was replaced by 120 mM choline, 120 mM LiCl, or 120 mM N-methyl-D-glucamine (NMDG), respectively. For uptake measurements, HEK-cells were plated into 24-well dishes (diameter ϭ 2 cm), and the culture medium was replaced by 0.2 ml of transport buffer TB1 containing 250 nM [ 3 H]5-HT (unless otherwise stated). After 3 min at room temperature, the medium was rapidly removed, and the cells were washed twice with TB1 before extraction with 0.4 ml of 10% (wt͞vol) sodium dodecyl sulfate. Radioactivity was determined by scintillation counting in a Beckman LS60001IC scintillation counter. To obtain comparable transport parameters with SERT wild-type (wt) and mutant proteins, HEK-293 cells were grown to 70% confluency in 24-well plates and transfected with 1 g per well of the respective cDNA as described (11) , and transport rates were determined in parallel at the same day. Specific uptake or binding was defined as the difference between the data obtained with transfected and mocktransfected cells (11) from the same set of cultures. Each experiment was repeated at least twice. All data represent the mean of triplicate determinations for binding experiments and of quadruplicate determinations for uptake studies. Standard deviations were routinely Ͻ7% and are indicated where larger than the symbols used. Data were analyzed by a nonlinear regression analysis program (XACT; Atari), which fitted sigmoidal uptake curves to the following equations: 
RESULTS
Effects of Serine Substitutions in SERT on 5-HT Uptake. To determine whether the three serine residues (S545, S555, and S559) located in TMD11 have a role in the uptake of 5-HT by and antidepressant binding to the rat SERT, we replaced the codons for these residues in the SERT1 cDNA with alanine triplets and expressed the resulting mutants in HEK-293 cells for binding and uptake studies. Initial experiments indicated that the transport of Table 1 ). In contrast, mutant S545A showed a reduced transport affinity with a K m value of 2.92 Ϯ 0.47 M and a loss of positive cooperativity as revealed by a Hill coefficient of n H ϭ 1.1 Ϯ 0.06. We therefore analyzed the properties of this mutant in more detail.
Characterization of [ 3 H]5-HT Uptake by the S545A Mutant. Kinetic studies showed that the initial rates of [ 3 H]5-HT uptake were linear within the first 3 min for both S545A and wt SERTs (Fig. 1A) . However, after 30 min cells transfected with the S545A cDNA had accumulated significantly higher amounts of [ 3 H]5-HT than those expressing wt transporters ( Fig. 1 A) . To extend this observation, saturation experiments with increasing concentrations of 5-HT were performed (Fig.  1B) . This revealed that S545A SERT had a consistently (n ϭ 3) higher V max (37 Ϯ 11 pmol͞min per well) than wt SERT (19 Ϯ 4.4 pmol͞min per well) and all other mutant SERTs tested simultaneously (see above). This is unlikely to reflect a better efficiency of S545A mutant transporter expression, since the levels of cell surface staining with a SERT-specific antibody (23) did not differ from those of cells expressing the wt and the S555A and S559A mutant proteins (data not shown). Accordingly, replacement of serine 545 by alanine All experiments were performed at least three times in quadruplicate. Vmax values are reported as percent of wt SERT in NaCl medium, 19 Ϯ 4.4 pmol͞min per well. Since the uptake of 5-HT by recombinant SERT is sodium dependent (13, 24) , we analyzed the cation dependence of 5-HT transport mediated by the S545A mutant transporter. As shown in Fig.  2A , a similar V max value was reached with S545A upon replacement of NaCl by LiCl [V max (NaCl) ϭ 25.2 Ϯ 8.3 pmol͞min per well; V max (LiCl) ϭ 23.0 Ϯ 7.3 pmol͞min per well]. This corresponds to 98.5% Ϯ 1.5% of the transport seen in NaCl, a value that is very different from the strong reduction in V max (Ϸ80%) observed with the wt protein under the same conditions ( Table 1) . As indicated by a shift of the substrate concentration curve to the right, the affinity of 5-HT transport was reduced in the presence of LiCl [K m 
A similar 2-to 3-fold increase of the K m value upon Na ϩ replacement by Li ϩ has also been observed for the wt SERT (P.S., unpublished results). In contrast, when NaCl was replaced by choline or NMDG, no transport was observed (1.3% Ϯ 0.01% and 3.5% Ϯ 2.3% of the uptake in NaCl medium, respectively) (Fig. 2B) . These results indicate that the S545A SERT mutant has lost its selectivity for Na ϩ , as Li ϩ can fully substitute for Na ϩ in providing the driving force for substrate translocation.
[ 
DISCUSSION
Following the premise that serine residues might be involved in 5-HT recognition by the SERT, we have mutated three serine residues located in TMD11 of the rat SERT (S545, S555, and S559). Whereas mutation of the two latter residues did not alter the transport characteristics of SERT, replacement of serine-545 by alanine resulted in significant changes of transport parameters. Consequently, the effects of this point mutation on 5-HT uptake and antidepressant binding parameters were analyzed in more detail. We report that serine at position 545 is involved in the Na ϩ dependence of 5-HT transport as well as in high-affinity binding of imipramine but not citalopram.
Mutant S545A Is a Fast Translocating Transporter. The S545A mutant accumulates 5-HT with an increased velocity as compared with the wt protein, suggesting modified kinetics of 5-HT transport. The uptake process can be simply described by the following Michaelis-Menten equation:
where E is the concentration of transporter and S out and S in are the concentrations of 5-HT outside and inside the cell, respectively; k ϩ1 , k Ϫ1 and k ϩ2 , k Ϫ2 are kinetic constants related to 5-HT binding (k ϩ1 , k Ϫ1 ) and 5-HT translocation (k ϩ2 , k Ϫ2 ). The constant k ϩ2 includes the kinetic constants of the multiple steps associated with substrate translocation. Under our experimental conditions (fast washing of the cells after a 3-min period of substrate uptake), we can assume that the efflux of 5-HT (k Ϫ2 ) was negligible. Therefore, the maximal transport rate (V max ) is equivalent to V max ϭ k ϩ2 ES. Thus, the increased V max observed with the mutant S545A most probably results from an increased k ϩ2 . According to the Michaelis-Menten equation [K m ϭ (k Ϫ1 ϩ k ϩ2 )͞k ϩ1 ], an increase in k ϩ2 should increase the apparent K m value of the substrate, given that the substrate binding affinity (k Ϫ1 ͞k ϩ1 ) does not change. Indeed, we found a 2-to 3-fold-increased K m value for 5-HT transport by the mutant S545A but no alteration in the binding of 5-HT as estimated by its unchanged potency in displacing [ 3 H]citalopram from both S545A and wt SERT-containing membranes. This is consistent with substitution of serine-545 not impairing 5-HT binding, but creating a SERT with a faster substrate translocation rate.
Sodium-Independent Transport of 5-HT by the S545A Mutant. Transport of 5-HT is a sodium-dependent process as determined in [ 3 H]5-HT uptake experiments (13, 24) and electrophysiological recordings from Xenopus oocytes expressing recombinant wt SERT (25) . In uptake experiments, replacement of external Na ϩ by Li ϩ resulted in a reduction of the maximal transport rate to Ϸ15-20% of the control value (13, 24) . Sodium ions are thought to be cotransported with 5-HT molecules at a 1:1 stoichiometry and to provide the electrochemical gradient for substrate transport (24) . It is proposed that binding of Na ϩ as well as of 5-HT to the extracellular side of the transporter triggers a conformational change, which allows the protein to initiate a complete transport cycle (26) . Interestingly, SERT bears at least two sodium binding sites as shown by a sigmoidal curve of Na ϩ dependence of imipramine binding to platelet membranes and the cooperative binding of two Na ϩ ions associated with transient currents recorded in oocytes (8, 25) . Electrophysiological analysis of the ␥-aminobutyric acid transporter, GAT1, also supports the view that Na ϩ binding promotes a conformational change which facilitates substrate binding and thereby translocation (27, 28) . Biochemical evidence for Na ϩ -induced conformational changes has also been obtained for the rat glutamate transporter (29) .
Our finding that 5-HT transport mediated by the S545A mutant is as efficient in Li ϩ -as in Na ϩ -containing media suggests that the mutant SERT is already in an activated conformation, which normally is assumed only upon Na ϩ binding. This conformation can immediately bind 5-HT and proceed into the transport cycle. Thus, Na ϩ ions seem to be essential for an initial step of the transport cycle, but not for 5-HT translocation into the cytoplasm per se. Such a Na ϩ - induced ''pre-activation step'' may in addition reflect the positive cooperativity of substrate transport seen with the wt rat (this study) and human SERT (30) , as well as with GAT1 (28) . In contrast, no positive cooperativity was observed with the S545A mutant. This is consistent with this mutant existing already in a conformational state that normally is achieved only upon Na ϩ binding.
Serine-545: A Putative Determinant of the External Gate? Electrophysiological studies of Na ϩ ͞Cl Ϫ -dependent transporters support the concept that transporters share numerous similarities with ion channels, such as ligand-dependent gating processes, selectivity filters, and hydrophilic permeation pathways (25, 31) . Consistent with this idea, binding of 5-HT and Na ϩ to the transporter may promote a conformational change leading to the opening of a gate, and thus initiate substrate translocation. We propose that serine-545 is a determinant of the Na ϩ binding domain of such a gate, which is constitutively open in mutant S545A. The 5-HT translocation step then can also be driven by other cations like Li ϩ ; the Na ϩ selectivity of the transport-associated permeation pathway thus appears not stringent. This implies that the transport of 5-HT by SERT is Na ϩ dependent, whereas its translocation across the membrane is not.
Previously proposed models of the transmembrane organization of the SERT and related transporter proteins place serine-545 into the center of the TMD11 (12, 32) . Notably, this residue is followed by a highly conserved proline residue. We propose that this proline induces a kink in the transmembrane ␣-helix and thus makes S545 accessible to Na ϩ . Imipramine Binding to Mutant S545A. SERT is the target of tricyclic antidepressants and selective 5-HT re-uptake inhibitors. We have previously identified two allosterically interacting antidepressant binding sites (ABS) on rat SERT heterologously expressed in HEK-293 cells (11) . ABS1 binds imipramine with high affinity, whereas ABS2 constitutes a high-affinity citalopram binding site that recognizes imipramine only with lower affinity (Ͼ100 nM). We also provided evidence that ABS2 most probably corresponds to a large binding pocket that accomodates citalopram, imipramine, and 5-HT binding subsites (11) . Moreover, it has been shown that the high-affinity imipramine binding site is Na ϩ dependent (11, 26, 33), whereas its low-affinity site is not (11, 33) . The latter could be identified only by the ability of imipramine to Pharmacology and Electrophysiology of SERT: A Joint Model. The conclusions emerging from this and previous studies (11) together with the evidence that SERT shares characteristics of ion channels (25) At rest, transport gates are slightly opened, which allows for a leakage current driven by Na ϩ , Li ϩ , or K ϩ (25). State 2: Binding of 5-HT and Na ϩ to a gate site which may include serine-545 triggers a conformational change that pre-activates the transporter. This binding domain associated with the gate is proposed to contain the high-affinity imipramine binding site (F). State 3: The substrate and the cotransported ions bind to the translocation domain (T), which probably contains overlapping low-affinity imipramine (E) and citalopram (s) binding sites. State 4: The external gate closes, the internal gate opens, and 5-HT, Na ϩ , and Cl Ϫ are released to the cytoplasm. The mechanism of dissociation of 5-HT and Na ϩ from the gating domain remains speculative at this stage. Subsequently a K ϩ ion enters the permeation pathway to be released in to the extracellular medium. The depicted localization of both gates at the edges of the transporter is hypothetical and was chosen for simplicity. alternating channel access model of transport described by Mager and colleagues (25) . Accordingly, completion of a transport cycle is a dynamic process, during which SERT undergoes the following distinct conformational alterations: (i) At rest (state 1), the external and internal gates are only slightly open to allow for a leakage current driven by Na ϩ , Li ϩ , or K ϩ . (ii) Binding of Na ϩ and 5-HT to a gate domain promotes a conformational change (state 2) which prepares the transporter for translocation. Serine-545 is likely to constitute an important determinant of this gate binding domain. Imipramine may interact at this site with high affinity, since its high-affinity binding is Na ϩ dependent (11, 26, 33) and competitively inhibited by 5-HT with an affinity [IC 50 ϭ 252 nM (11)] higher than its K m for transport (1 M; Table 1 ). (iii) In a subsequent step, the external gate opens (state 3), and 5-HT, Na ϩ , or Li ϩ and Cl Ϫ bind to the substrate translocation domain. Substitution of alanine for serine-545 is postulated to create a SERT which is constitutively held in this state. The translocation binding domain contains also subsites for highaffinity citalopram and low-affinity imipramine binding. In mutant S545A, these antidepressant subsites are not altered; however, citalopram and imipramine have a reduced potency to antagonize uptake, suggesting that their inhibitory action may take place at a step upstream of the opening of the ligand-dependent gate. (iv) In the terminal step (state 4), the external gate is closed and the internal gate is opened. This allows the substrate to be released on the cytoplasmic side together with the cotransported ions. At this stage, a K ϩ ion is trapped in the transporter permeation pathway. Its release into the extracellular medium upon reassuming state 1 will terminate the transport cycle.
Conclusion. Our data show that serine residue 545 of rat SERT plays a key role in the sodium dependence of 5-HT transport and in high-affinity imipramine binding. They also demonstrate that Li ϩ can be efficiently cotransported with the substrate, suggesting that the permeation pathway is not selective for Na ϩ . The control of uptake properties by a hydroxyl-containing side chain in TMD11 may also apply to related carriers, since serine-545 is conserved or isofunctionally replaced by threonine in several Na ϩ ͞Cl Ϫ -dependent neurotransmitter transporters.
